Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The COVID-19 pandemic has major implications for blood transfusion. There are uncertain patterns of demand, and transfusion institutions need to plan for reductions in donations and loss of crucial staff because of sickness and public health restrictions. We systematically searched for relevant studies addressing the transfusion chain-from donor, through collection and processing, to patients-to provide a synthesis of the published literature and guidance during times of potential or actual shortage. A reduction in donor numbers has largely been matched by reductions in demand for transfusion. Contingency planning includes prioritisation policies for patients in the event of predicted shortage. A range of strategies maintain ongoing equitable access to blood for transfusion during the pandemic, in addition to providing new therapies such as convalescent plasma. Sharing experience and developing expert consensus on the basis of evolving publications will help transfusion services and hospitals in countries at different stages in the pandemic.

Original publication

DOI

10.1016/S2352-3026(20)30186-1

Type

Journal article

Journal

Lancet Haematol

Publication Date

10/2020

Volume

7

Pages

e756 - e764

Keywords

Antibodies, Viral, Betacoronavirus, Blood Banks, Blood Coagulation Disorders, Blood Donors, Blood Preservation, Blood Safety, Blood Transfusion, COVID-19, Coronavirus Infections, Donor Selection, Elective Surgical Procedures, Health Care Rationing, Health Policy, Health Services Needs and Demand, Hemoglobinopathies, Humans, Immunization, Passive, Pandemics, Pneumonia, Viral, Randomized Controlled Trials as Topic, SARS-CoV-2